Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy

Ophthalmology Retina(2021)10.1016/j.oret.2021.06.001Source: DataRank Database

Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy is a research paper published in Ophthalmology Retina (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.62)OA: greenTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Julia Canestraro ORCID,Dianna Haggag-Lindgren ORCID,James J. Harding ORCID,Eli L. Diamond ORCID,Alexander Drilon ORCID

Live enrichment

PubMed:34102344 PMC:PMC10977084 OpenAlex:https://openalex.org/W3171576736

Jiangsu Hengrui Medicine

Grant: US62/514

Jiangsu Hengrui Medicine

Grant: US62/685,057

National Cancer Institute

Grant: P30 CA008748

FWCI

1.62

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10977084

publisherhttps://api.elsevier.com/content/article/PII:S2468653021001779?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468653021001779?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.oret.2021.06.001

Fields of Study

Ocular Oncology and TreatmentsDrug-Induced Ocular ToxicityMelanoma and MAPK PathwaysAdultAgedCentral Serous ChorioretinopathyExtracellular Signal-Regulated MAP KinasesFemaleFluorescein AngiographyFollow-Up StudiesFundus OculiHumansMaleMiddle AgedNeoplasmsPrognosisProtein Kinase InhibitorsRetinal Pigment EpitheliumRetrospective StudiesTomography, Optical CoherenceVisual AcuityYoung Adult

MeSH Terms

AdultAgedFemaleFluorescein AngiographyFollow-Up StudiesFundus OculiHumansMaleMiddle AgedNeoplasmsPrognosisRetrospective StudiesVisual AcuityTomography, Optical CoherenceProtein Kinase InhibitorsExtracellular Signal-Regulated MAP KinasesRetinal Pigment EpitheliumYoung AdultCentral Serous Chorioretinopathy

Keywords

MedicineOphthalmologySerous fluidVisual acuityRetinalEdemaFundus (uterus)Retinal pigment epitheliumRetinopathyMacular edemaRetinaConcomitantChoroidOuter nuclear layerFundus photographyFluorescein angiographyPathologySurgeryEndocrinologyDiabetes mellitusCentral Serous ChorioretinopathySubretinal FluidMek InhibitorErk Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being

Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy

FAIR Checklist

Authors (10)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)